Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 1
2019 pubmed 1 citations

[Clinical significance of antibacterial peptide LL-37 in early diagnosis of patients with sepsis in emergency department].

Liu. Anping A; Zhou. Yang Y; Ye. Peng P; Zhang. Xiaojun X; Luo. Yinghua Y; Yu. Anyong A; Wang. Song S

Key Findings

  • LL-37 levels were dramatically higher in sepsis patients (1.34 µg/L) than in healthy people (0.10 µg/L).
  • LL-37 correlated strongly with established infection markers PCT (r=0.835) and CRP (r=0.932).
  • Combined testing of LL-37, PCT, and CRP achieved an AUC of 0.994, with 97.5% sensitivity and 95% specificity for early sepsis detection.

Practical Outcomes

  • For most biohackers, this finding isn’t directly actionable because LL-37 testing isn’t a routine at‑home assay and sepsis is an acute medical emergency. However, it suggests that if you ever have access to clinical labs, adding LL-37 to standard infection panels could improve early diagnosis, though it’s not a protocol you can self‑implement for longevity or performance goals.

Summary

The study found that the blood protein LL-37 rises a lot in people with early sepsis, and its level tracks closely with other infection markers (PCT and CRP). Measuring LL-37 together with those markers gives a very accurate way to spot sepsis early in the emergency room.

Abstract

To discuss the clinical significance of antibacterial peptide LL-37 in the early diagnosis of patients with sepsis in emergency department. Forty patients diagnosed with sepsis in the emergency department of the Affiliated Hospital of Zunyi Medical College from December 2017 to March 2018 were enrolled as sepsis group. Twenty healthy volunteers were enrolled contemporaneously in our hospital at medical center as healthy control group. Peripheral blood was collected immediately after diagnosis in sepsis group or during physical examination in healthy control group. The expression of antibacterial peptide LL-37 was determined by enzyme-linked immunosorbent assay (ELISA). Meanwhile, serum procalcitonin (PCT) and C-reactive protein (CRP) levels were determined. The differences in antibacterial peptide LL-37, PCT and CRP levels between the two groups were compared. Pearson correlation method was used to analyze the correlation between antibacterial peptide LL-37, PCT and CRP. Receiver operating characteristic (ROC) curve was drawn, and the early individually or jointly diagnostic value of each detected index for sepsis was analyzed. The levels of antimicrobial peptide LL-37, PCT and CRP in peripheral blood of sepsis group were significantly higher than those of healthy control group [LL-37 (&#x3bc;g/L): 1.34&#xb1;0.69 vs. 0.10&#xb1;0.06, PCT (&#x3bc;g/L): 46.67&#xb1;39.51 vs. 0.03&#xb1;0.02, CRP (mg/L): 129.68&#xb1;49.83 vs. 3.16&#xb1;2.85], with statistically significant differences (all P &lt; 0.05). Pearson correlation analysis showed that the expression of antimicrobial peptide LL-37 was positively correlated with PCT and CRP levels (r<sub>1</sub> = 0.835, r<sub>2</sub> = 0.932, both P &lt; 0.01). ROC curve analysis showed that the area under ROC curve (AUC) of LL-37, PCT and CRP for early diagnosis of sepsis was 0.885, 0.963 and 0.983, respectively, and the AUC of combined diagnosis of the three parameters was as high as 0.994, indicating that the value of combined diagnosis of sepsis was greater than that of single diagnosis; when the combined prediction probability of the three parameters was 0.92, the sensitivity was 97.5%, and the specificity was 95.0%. Antibacterial peptide LL-37 has certain clinical value in early diagnosis of patients with sepsis, which can be used as early routine monitoring indicators for patients with early sepsis when combined with PCT and CRP.

Study Information

Provider

pubmed

Year

2019

Date

2019-09-01T00:00:00.000Z

DOI

10.3760/cma.j.issn.2095-4352.2019.09.005

Citations

1